Dr. Hazan and dr. Urso about Remdesivir

Dr. Sabine Hazan: "We're working with these guidelines and these hospitals are supported by pharmaceutical companies. When Gilead pays a hospital $100,000 per patient to try the drug, the hospital's gonna go: You know what, let me give Remdesivir.. They're not gonna give a cheap drug like hydroxychloroquine or ivermectin."
Dr. Richard Urso: "A respiratory viruses, basically all of them, adenovirus, rhinovirus, all of them all very short lived. And somehow still they press this who Remdesivir thing when it clearly couldn't be effective. It's crazy."